Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: A pilot study in China

Haemophilia

Volumn 17, Issue 1, 2011, Pages 70-74

  Wu, R ^a   Luke, K H ^b   Poon, M C ^c   Wu, X ^a   Zhang, N ^a   Zhao, L ^a   Su, Y ^a   Zhang, J ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Children; Developing countries; Low dose prophylaxis; Moderate haemophilia; Secondary prophylaxis; Severe haemophilia

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ARTICLE; CHILD; CHINA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DAILY LIFE ACTIVITY; DISEASE SEVERITY; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HUMAN; JOINT FUNCTION; LOW DRUG DOSE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; SPORTING EVENT; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; DEVELOPING COUNTRIES; FACTOR IX; FACTOR V; FEMALE; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS;

EID: 79951898096     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02348.x     Document Type: Article

References (18)

1. Manco-Johnson MJ, Riske B, Kasper CK. Advances in care of children with hemophilia. Semin Thromb Haemost 2003; 29: 585-94.
2. Steen Carlsson K, Hojgard S, Glomstein A et al. On demand vs. prophylactic treatment for severe hemophilia in Norway and Sweden: differences in treatment characteristics and outcome. Haemophilia 2003; 9: 555-66.
3. Zhang L, Li H, Zhao H, Zhang X, Ji L, Yang R. Retrospective analysis of 1312 patients with hemophilia and related disorders in a single Chinese institute. Haemophilia 2003; 9: 696-702.
4. Guo Ye, Zhang L, Zhu X, Yang R. The retrospective survey of 429 children hemophilia in China. Chin J Pract Pediatr 2006, 21: 293-5 (in Chinese).
5. Wu RH, Wu XY, Zhang NN, Zhang JS, Sui Y. Evaluation clinical data and current condition of children hemophilic patients in China. Chin J Thromb Haemost 2008; 14:116-20 (in Chinese).
6. Chuansumrit A, Krasaesub S, Angchaisuksiri P, Hathirat P, Isarangkura P. Survival analysis of patients with haemophilia at the International Haemophilia Training Centre, Bangkok, Thailand. Haemophilia 2004; 10: 542-9.
7. Kulkarni ML, Nanda G. Hemophiliacs - a picture from a developing country: Karnataka, a south Indian state. Southeast Asian J Trop Med Public Health 1993; 24(Suppl. 1): 270-3.
8. Evatt BL. Demographics of hemophilia in developing countries. Semin Thromb Haemost 2005; 31: 489-94.
9. Poon MC, Luke KH. Haemophilia care in China: achievement of a decade of World Federation of Hemophilia treatment centre twinning activities. Haemophilia 2008; 14: 879-88.
10. World Federation of Hemophilia. Guidelines for the Management of Hemophilia, 2005. Available at or
11. Gilbert MS. Prophylasxis: musculoskeletal evaluation. Semin Hematol 1993; 30(Suppl. 2): 3-6.
12. Carcao MD, Aledort LM. Prophylaxis in the hemophilia population-optimizing therapy. Haemophilia 2007; 13: 227-32.
13. Feldman BM, Pai M, Rivard GE et al. Tailored prophylaxis in severe hemophilia A: interim results from the first 5years of the Canadian Hemophilia Primary Prophylaxis Study. J Thromb Haemost 2006; 4: 1228-36.
14. Nilsson IM, Berntorp E, Lofqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Inst Med 1992; 232: 25-32.
15. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
16. O'Mahony B. Global haemophilia care: future challenges and opportunities. Haemophilia 2002; 8: 515.
17. Jansen NW, Roosendaal G, Bijlsma JW, Degroot J, Lafeber FP. Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study. Arthritis Rheum 2007; 56: 199-207.
18. Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor VIII deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994; 236: 391-9.